Even though sugars are often framed as simple sources of energy, they also serve as structurally complex and functionally diverse molecules that mediate interactions between organisms. Among these, ...
All Evaluable Patients Achieved Improvements in Multiple Hallmarks of MYBPC3-Associated HCM Benefits Among Cohort 1 Patients ...
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported promising new interim safety and efficacy data from the company’s MyPEAK™-1 ...
Science can already tell you what a molecule is and what it looks like. What it has never been able to tell you, cheaply and at scale, is how the thing behaves once it meets the messy conditions of ...
Dr. Nandkumar M. Kamat Along the saline margins of the Chapora estuary survives an old Goan winter cowpea locally known as alsande black-eyed pea or Vigna unguiculata subsp. unguiculata. For ...
Bibigo drives overseas growth as bio slump cuts CJ CheilJedang profit Overseas dumplings lift sales as bio margin squeeze ...
Good morning, and welcome to the Equillium Virtual Investor Event. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Equillium website ...
US FDA accepts for priority review Bristol Myers Squibb’s sNDA for Camzyos to treat adolescents with symptomatic obstructive hypertrophic cardiomyopathy: Princeton, New Jersey T ...
Simon May - Senior VP and President of Life Sciences & Diagnostics Markets Group Mike Zhang - Senior VP & President of Applied Markets Group Thank you, Karina, and welcome, everyone, to Agilent's ...
The real question of Elon Musk’s lawsuit against OpenAI was whether the company’s corporate transformation was cynical in intention or merely in outcome. Musk may have lost the case, but the trial was ...
Detailed price information for Cellectar Biosciences Inc (CLRB-Q) from The Globe and Mail including charting and trades.
Deramiocel BLA under active FDA review; PDUFA target action date of August 22, 2026; labeling discussions expected to commence soonHOPE-3 Phase 3 trial met its primary endpoint (PUL v2.0; upper limb ...